title: [The influence of ursodeoxycholic acid on hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan in chronic liver diseases].
authors.forename: T
authors.initials: T
authors.lastname: Hayakawa
authors.forename: K
authors.initials: K
authors.lastname: Katagiri
authors.forename: S
authors.initials: S
authors.lastname: Shiraka
authors.forename: T
authors.initials: T
authors.lastname: Nakai
authors.forename: A
authors.initials: A
authors.lastname: Takeshima
authors.forename: Y
authors.initials: Y
authors.lastname: Kawamura
authors.forename: H
authors.initials: H
authors.lastname: Ohnishi
authors.forename: M
authors.initials: M
authors.lastname: Hoshino
authors.forename: K
authors.initials: K
authors.lastname: Tsukada
authors.forename: M
authors.initials: M
authors.lastname: Miyani
mesh_terms: D000328:Adult; D001659:Biliary Tract / Q000000981:diagnostic imaging*; D002908:Chronic Disease; D003840:Deoxycholic Acid / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging*; D008107:Liver Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; D011730:Pyridoxal / Q000031:analogs & derivatives*; D011877:Radionuclide Imaging; D014364:Tryptophan / Q000031:analogs & derivatives*; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
chemical_list: D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; C038081:technetium Tc 99m pyridoxyl-5-methyltryptophan; D003840:Deoxycholic Acid; D011730:Pyridoxal; D014580:Ursodeoxycholic Acid; D014364:Tryptophan